Split Rock Partners, LLC, established in 2004 and headquartered in Eden Prairie, Minnesota, is a venture capital firm focusing on early-stage investments in the Upper Midwest and West Coast regions of the United States. The firm specializes in healthcare and software, internet, and internet-based services companies, with a particular interest in medical devices and enterprise software. Split Rock Partners invests in companies with a market size exceeding $500 million, aiming for investments of $8 million to $10 million, and seeks to generate returns through strategic growth, spin-outs, or restructurings. The firm prefers to lead or co-lead initial investments and takes an active role in portfolio companies, often serving on the board and chairmanship.
Gravie, Inc. is a health insurance platform based in Minneapolis, Minnesota, that provides health insurance plans for individuals, families, and employers. Established in 2013, Gravie enables users to compare insurance options available through government-run marketplaces as well as directly from insurance companies. The company specializes in designing tailored benefits plans for employees, managing payments, and offering year-round support. Its services include Gravie Care, which allows individuals to shop for their benefits, and it utilizes a mobile application and website for ease of access. Gravie's innovative approach includes a defined contribution model, allowing employers to set fixed annual budgets for health benefits while providing tools for effective cost management. The platform also facilitates a better understanding of healthcare expenses through detailed price comparisons and information on co-pays, co-insurance, and applicable tax credits.
Gravie
Series E in 2022
Gravie, Inc. is a health insurance platform based in Minneapolis, Minnesota, that provides health insurance plans for individuals, families, and employers. Established in 2013, Gravie enables users to compare insurance options available through government-run marketplaces as well as directly from insurance companies. The company specializes in designing tailored benefits plans for employees, managing payments, and offering year-round support. Its services include Gravie Care, which allows individuals to shop for their benefits, and it utilizes a mobile application and website for ease of access. Gravie's innovative approach includes a defined contribution model, allowing employers to set fixed annual budgets for health benefits while providing tools for effective cost management. The platform also facilitates a better understanding of healthcare expenses through detailed price comparisons and information on co-pays, co-insurance, and applicable tax credits.
Gravie
Series D in 2021
Gravie, Inc. is a health insurance platform based in Minneapolis, Minnesota, that provides health insurance plans for individuals, families, and employers. Established in 2013, Gravie enables users to compare insurance options available through government-run marketplaces as well as directly from insurance companies. The company specializes in designing tailored benefits plans for employees, managing payments, and offering year-round support. Its services include Gravie Care, which allows individuals to shop for their benefits, and it utilizes a mobile application and website for ease of access. Gravie's innovative approach includes a defined contribution model, allowing employers to set fixed annual budgets for health benefits while providing tools for effective cost management. The platform also facilitates a better understanding of healthcare expenses through detailed price comparisons and information on co-pays, co-insurance, and applicable tax credits.
Gravie
Series D in 2021
Gravie, Inc. is a health insurance platform based in Minneapolis, Minnesota, that provides health insurance plans for individuals, families, and employers. Established in 2013, Gravie enables users to compare insurance options available through government-run marketplaces as well as directly from insurance companies. The company specializes in designing tailored benefits plans for employees, managing payments, and offering year-round support. Its services include Gravie Care, which allows individuals to shop for their benefits, and it utilizes a mobile application and website for ease of access. Gravie's innovative approach includes a defined contribution model, allowing employers to set fixed annual budgets for health benefits while providing tools for effective cost management. The platform also facilitates a better understanding of healthcare expenses through detailed price comparisons and information on co-pays, co-insurance, and applicable tax credits.
EBR Systems
Venture Round in 2019
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.
Nuvaira
Series E in 2019
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.
EBR Systems
Venture Round in 2017
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.
TruSignal
Series A in 2017
TruSignal, LLC, based in St. Cloud, Minnesota, specializes in digital marketing services, focusing on people-based marketing technology for Fortune 500 brands, agencies, and publishers. As a subsidiary of TransUnion, TruSignal leverages predictive scoring and artificial intelligence to transform large data sets into actionable insights for personalized marketing. The company's TruAudience Platform integrates a deterministic identity graph, extensive third-party data, and advanced machine learning algorithms. This platform enables clients to identify and target the most relevant audiences effectively, optimize bidding strategies for digital impressions, and facilitate audience expansion and custom audience creation. By utilizing cross-channel ID matching and robust integration APIs, TruSignal aims to deliver measurable business growth through enhanced marketing initiatives.
Gravie
Series C in 2017
Gravie, Inc. is a health insurance platform based in Minneapolis, Minnesota, that provides health insurance plans for individuals, families, and employers. Established in 2013, Gravie enables users to compare insurance options available through government-run marketplaces as well as directly from insurance companies. The company specializes in designing tailored benefits plans for employees, managing payments, and offering year-round support. Its services include Gravie Care, which allows individuals to shop for their benefits, and it utilizes a mobile application and website for ease of access. Gravie's innovative approach includes a defined contribution model, allowing employers to set fixed annual budgets for health benefits while providing tools for effective cost management. The platform also facilitates a better understanding of healthcare expenses through detailed price comparisons and information on co-pays, co-insurance, and applicable tax credits.
Demandbase
Series H in 2017
Demandbase is a developer of an account-based marketing platform tailored for business-to-business (B2B) companies seeking to optimize their revenue generation while utilizing fewer resources. The platform integrates advertising, marketing, sales, and analytics, allowing sales and marketing professionals to effectively identify and engage with high-potential accounts. By leveraging a combination of proprietary data and artificial intelligence, Demandbase enables organizations to align their sales and marketing efforts, ensuring that time and budget are directed toward accounts most likely to convert. Additionally, the company offers a pay-as-you-go service for acquiring B2B marketing lists, sales leads, and email marketing solutions, thereby enhancing clients' overall marketing performance.
Sparkcentral
Venture Round in 2016
Sparkcentral Inc. is a company that offers an enterprise social media helpdesk platform designed to facilitate high-volume and real-time customer engagement. The Sparkcentral platform allows customer support teams to efficiently manage social inquiries by consolidating messages from various channels into a secure agent console, which automatically assigns requests to available agents. This system enhances workflow through features like automated responses, internal collaboration, and engagement metrics, ultimately improving customer satisfaction. Sparkcentral serves a diverse client base, including major brands such as Delta Air Lines, Netflix, and T-Mobile. The company, founded in 2012 and headquartered in San Francisco, California, has established strategic partnerships with industry leaders such as Genesys and Calabrio to further enhance its service offerings.
Janrain
Series D in 2015
Janrain, Inc. is a leading provider of customer identity and access management (CIAM) solutions, renowned for developing the Janrain Identity Cloud, a comprehensive platform that enables real-time identity management, security, and customer activation for enterprises globally. Founded in 2002 and headquartered in Portland, Oregon, Janrain has established itself as a pioneer in the CIAM market, being the inventor of social login and a founding member of the OpenID Foundation. The company's technology allows organizations to streamline user login processes and gain insights into customer behavior by analyzing social and login data, thereby minimizing fraud. Janrain serves a diverse range of sectors, including consumer brands, financial services, healthcare, and retail, and has expanded its presence with offices across the United States, Europe, and Asia. As of early 2019, Janrain operates as a subsidiary of Akamai Technologies, further enhancing its capabilities in identity management.
Code42
Series B in 2015
Code42 specializes in data loss protection, visibility, and recovery solutions designed to safeguard critical information from various threats, including insider breaches. Its platform offers a secure cloud service that continuously and automatically collects data via a lightweight agent installed on devices, ensuring comprehensive protection for files on laptops and desktops. The company's solutions enable security, IT, and compliance professionals to quickly detect threats, meet regulatory requirements, and accelerate incident response without complex policy management or hindering user collaboration. By focusing on ease of use and effective data management, Code42 helps organizations maintain a secure environment while fostering a collaborative workplace culture.
Acquia
Series G in 2015
Acquia Inc., established in 2007, is a technology company based in Boston, Massachusetts, with an additional office in Pune, India. It specializes in developing and operating a cloud-based platform that empowers organizations to create, manage, and optimize digital experiences. Acquia's platform offers a range of solutions, including commerce, content, community, and contextual services, catering to diverse industries such as government, consumer brands, higher education, and more. Key products include Acquia Cloud, a Platform-as-a-Service for Drupal website creation and management; Acquia Lift for site templating; Acquia Content Hub for multi-channel content distribution; and Acquia Journey for data-driven customer journey creation. Acquia also provides web content management, security, commerce solutions, and technical support services. The company's platform enables organizations to accelerate time to market, enhance customer engagement, and deliver contextually relevant digital experiences across various channels.
InsideView
Private Equity Round in 2015
InsideView is a technology company that specializes in customer relationship management (CRM) software, focusing on providing actionable B2B data and intelligence. Founded in 2005 and headquartered in San Francisco, California, InsideView's Targeting Intelligence platform leverages machine learning and artificial intelligence to assist sales and marketing teams in redefining their go-to-market strategies from a volume-based model to a more targeted approach. This platform enables professionals to quickly identify and qualify optimal targets, engage with greater relevance, and enhance their capabilities to close deals and expand customer accounts. InsideView serves over 500,000 professionals across more than 20,000 leading companies, including notable names such as Adobe and Apple. The company's CRM integrations include partnerships with major platforms like Microsoft, Salesforce, and Oracle, while its content relationships extend to social media and data providers such as Facebook, LinkedIn, and Thomson Reuters.
Gravie
Series B in 2015
Gravie, Inc. is a health insurance platform based in Minneapolis, Minnesota, that provides health insurance plans for individuals, families, and employers. Established in 2013, Gravie enables users to compare insurance options available through government-run marketplaces as well as directly from insurance companies. The company specializes in designing tailored benefits plans for employees, managing payments, and offering year-round support. Its services include Gravie Care, which allows individuals to shop for their benefits, and it utilizes a mobile application and website for ease of access. Gravie's innovative approach includes a defined contribution model, allowing employers to set fixed annual budgets for health benefits while providing tools for effective cost management. The platform also facilitates a better understanding of healthcare expenses through detailed price comparisons and information on co-pays, co-insurance, and applicable tax credits.
EBR Systems
Venture Round in 2015
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.
Sparkcentral
Series B in 2015
Sparkcentral Inc. is a company that offers an enterprise social media helpdesk platform designed to facilitate high-volume and real-time customer engagement. The Sparkcentral platform allows customer support teams to efficiently manage social inquiries by consolidating messages from various channels into a secure agent console, which automatically assigns requests to available agents. This system enhances workflow through features like automated responses, internal collaboration, and engagement metrics, ultimately improving customer satisfaction. Sparkcentral serves a diverse client base, including major brands such as Delta Air Lines, Netflix, and T-Mobile. The company, founded in 2012 and headquartered in San Francisco, California, has established strategic partnerships with industry leaders such as Genesys and Calabrio to further enhance its service offerings.
Histogenics
Post in 2014
Histogenics Corporation, founded in 2000 and headquartered in Waltham, Massachusetts, is a regenerative medicine company specializing in the development and commercialization of therapeutic medical products for musculoskeletal conditions. The company's innovative platform integrates cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to address cartilage damage and improve joint function. Its primary investigational product, NeoCart, is a tissue implant designed to treat cartilage injuries in the knee, aiming to regenerate healthy cartilage and enhance overall joint performance. In 2019, Histogenics was acquired by Ocugen, Inc., marking a significant transition in its corporate structure.
VoloMetrix
Series B in 2014
VoloMetrix, Inc. is a people analytics technology company that specializes in optimizing organizational performance through the analysis of communication data. Founded in 2011 and headquartered in Seattle, with an additional office in San Francisco, VoloMetrix offers a platform that extracts and analyzes anonymized, aggregated data from corporate communication systems. This technology provides actionable insights through customizable dashboards, social network graphs, and predictive analytics, enabling organizations to enhance sales productivity, improve workforce planning, and simplify processes. The company serves a diverse range of industries, including banking, biotech, and professional services, primarily focusing on Fortune 500 companies. VoloMetrix's solutions aim to give executives visibility into employee behaviors and relationships, ultimately driving business outcomes and fostering employee engagement. As of 2015, VoloMetrix operates as a subsidiary of Microsoft Corporation.
Zyga Technology
Series D in 2014
Zyga Technology, Inc. is a medical device company focused on developing and commercializing minimally invasive products for underserved conditions of the lumbar spine. The company offers the SImmetry Sacroiliac Joint Fusion System, which provides a surgical solution for sacroiliac joint fusion, addressing issues such as joint disruptions and degenerative sacroiliitis. Additionally, Zyga is working on the Glyder Facet Restoration System, an investigational device aimed at treating chronic facetogenic pain. Founded in 2008 and based in Minnetonka, Minnesota, Zyga Technology has assembled a skilled team with extensive experience in the spine industry. As of late 2017, Zyga operates as a subsidiary of RTI Surgical, Inc.
Ivantis
Series B in 2014
Ivantis Inc. is a medical device company based in Irvine, California, focused on developing innovative treatments for primary open-angle glaucoma. Founded in 2007, the company specializes in a minimally invasive intracanalicular scaffold that alleviates high intraocular pressure by restoring the natural outflow pathway in Schlemm's canal. This device aims to provide a less invasive and more effective solution for the over 60 million individuals worldwide affected by this condition. In addition to its primary focus on glaucoma, Ivantis intends to explore innovative treatments for other ophthalmic diseases as it expands its product offerings. The company also provides a Session Persistence Server to support clinical trials, ensuring data protection for telnet task workers and terminal emulation users across various devices and operating systems.
Colorescience
Series B in 2014
Colorescience, Inc. is a skincare brand based in Carlsbad, California, specializing in mineral-based cosmetics and sunscreen products. Founded in 2000, the company offers a range of items, including treatment products, UV protectors, primers, foundations, and enhancers, designed to address various skin concerns such as pigmentation, redness, dark circles, and signs of aging. Colorescience emphasizes high-quality, dermatologist-recommended formulations that incorporate minerals, antioxidants, and botanicals to promote healthy skin and protect against sun damage. The brand markets its products through a network of licensed physicians, luxury spas, retailers, and online platforms, aiming to stand out in the aesthetic makeup segment by providing effective and easy-to-use solutions for diverse skin types.
BlackDuck
Series F in 2014
Black Duck secures and manages open source software worldwide, eliminating open source security vulnerabilities and license compliance pain. With the rapid, widespread adoption of open-source software, Black Duck is a key component of Synopsys’ Software Integrity Platform, the most comprehensive solution for integrating security into the SDLC and software supply chain. Black Duck was established in 2002 and is based in Burlington, Massachusetts, United States.
EBR Systems
Venture Round in 2014
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.
Acquia
Series F in 2014
Acquia Inc., established in 2007, is a technology company based in Boston, Massachusetts, with an additional office in Pune, India. It specializes in developing and operating a cloud-based platform that empowers organizations to create, manage, and optimize digital experiences. Acquia's platform offers a range of solutions, including commerce, content, community, and contextual services, catering to diverse industries such as government, consumer brands, higher education, and more. Key products include Acquia Cloud, a Platform-as-a-Service for Drupal website creation and management; Acquia Lift for site templating; Acquia Content Hub for multi-channel content distribution; and Acquia Journey for data-driven customer journey creation. Acquia also provides web content management, security, commerce solutions, and technical support services. The company's platform enables organizations to accelerate time to market, enhance customer engagement, and deliver contextually relevant digital experiences across various channels.
Nuvaira
Series D in 2014
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.
Transcend Medical
Series C in 2014
Transcend Medical, Inc. is an ophthalmic device company dedicated to developing medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005 and based in Menlo Park, California, the company emerged from ForSight Labs and focuses on minimally invasive solutions to replace traditional invasive therapies. Its flagship product, the CyPass Micro-Stent, is designed to be inserted during routine cataract surgery to help reduce intraocular pressure. Transcend Medical also offers the Vold Gonio Lens for use in micro-invasive glaucoma surgery and provides clinical trial services. The CyPass Micro-Stent received CE mark approval in 2008 and has been evaluated in various clinical studies, including the COMPASS multi-center trial. The company operates as a subsidiary of Alcon Holdings, Inc.
Sage Intacct
Series G in 2014
Sage Intacct, Inc. is a cloud accounting software company that specializes in delivering comprehensive financial management solutions for a variety of sectors including accounting, healthcare, hospitality, and nonprofits. Founded in 1999 and headquartered in San Jose, California, the company provides a robust suite of applications that encompass general ledger accounting, accounts payable, order management, cash management, financial reporting, and more. Sage Intacct also offers advanced functionalities such as project accounting, multi-entity consolidations, contract revenue management, and vendor payment services. The company focuses on customer success and innovation, serving clients from startups to public enterprises across North America. Sage Intacct is recognized for its exceptional customer satisfaction and has been appointed a preferred provider by the AICPA. With a commitment to cloud-based solutions, the company also offers extensive professional training and support services to enhance user experience.
Guardian Analytics
Series E in 2013
Guardian Analytics, Inc. is a provider of behavior-based fraud prevention solutions aimed at protecting financial institutions from online and mobile banking fraud. Established in 2005 and based in Mountain View, California, the company offers a range of services tailored for enterprise banks, community banks, and credit unions. These services include omni-channel fraud prevention, visual analytics, integrated risk databases, and cross-channel risk scoring. The platform utilizes behavioral analytics and machine learning to detect fraud in real-time across various payment methods, including online, mobile, ACH, and wire transfers. Additionally, Guardian Analytics provides a managed service called FraudDESK, which helps institutions mitigate fraud with minimal staffing impact. The company's solutions not only enhance fraud detection but also support anti-money laundering compliance, making them essential for over 400 financial institutions seeking to safeguard their operations and improve customer trust.
InsideView
Series D in 2013
InsideView is a technology company that specializes in customer relationship management (CRM) software, focusing on providing actionable B2B data and intelligence. Founded in 2005 and headquartered in San Francisco, California, InsideView's Targeting Intelligence platform leverages machine learning and artificial intelligence to assist sales and marketing teams in redefining their go-to-market strategies from a volume-based model to a more targeted approach. This platform enables professionals to quickly identify and qualify optimal targets, engage with greater relevance, and enhance their capabilities to close deals and expand customer accounts. InsideView serves over 500,000 professionals across more than 20,000 leading companies, including notable names such as Adobe and Apple. The company's CRM integrations include partnerships with major platforms like Microsoft, Salesforce, and Oracle, while its content relationships extend to social media and data providers such as Facebook, LinkedIn, and Thomson Reuters.
Vormetric
Venture Round in 2013
Vormetric, Inc. is a provider of data security solutions that safeguard sensitive information across various environments, including physical, virtual, and cloud settings. The company offers a comprehensive suite of products, including Vormetric Application Encryption, Vormetric Transparent Encryption, and Vormetric Cloud Encryption Gateway, which facilitate enterprise application encryption and secure cloud storage. Additionally, Vormetric Data Security Manager centralizes policy and key management, while Vormetric Key Management enhances security and compliance. The company's solutions also include Vormetric Live Data Transformation, security for Teradata databases, and tokenization services that de-identify sensitive data. Vormetric serves a diverse range of industries, including healthcare, finance, education, and government, and has established a strong customer base, with over 1,100 clients, including numerous Fortune 25 companies. Originally known as Sotera Networks, Inc., the company rebranded in 2002 and is currently headquartered in San Jose, California. As of 2016, Vormetric operates as a subsidiary of Thales e-Security, Inc.
Colorescience
Series A in 2013
Colorescience, Inc. is a skincare brand based in Carlsbad, California, specializing in mineral-based cosmetics and sunscreen products. Founded in 2000, the company offers a range of items, including treatment products, UV protectors, primers, foundations, and enhancers, designed to address various skin concerns such as pigmentation, redness, dark circles, and signs of aging. Colorescience emphasizes high-quality, dermatologist-recommended formulations that incorporate minerals, antioxidants, and botanicals to promote healthy skin and protect against sun damage. The brand markets its products through a network of licensed physicians, luxury spas, retailers, and online platforms, aiming to stand out in the aesthetic makeup segment by providing effective and easy-to-use solutions for diverse skin types.
Nuvaira
Series C in 2013
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.
Janrain
Series C in 2013
Janrain, Inc. is a leading provider of customer identity and access management (CIAM) solutions, renowned for developing the Janrain Identity Cloud, a comprehensive platform that enables real-time identity management, security, and customer activation for enterprises globally. Founded in 2002 and headquartered in Portland, Oregon, Janrain has established itself as a pioneer in the CIAM market, being the inventor of social login and a founding member of the OpenID Foundation. The company's technology allows organizations to streamline user login processes and gain insights into customer behavior by analyzing social and login data, thereby minimizing fraud. Janrain serves a diverse range of sectors, including consumer brands, financial services, healthcare, and retail, and has expanded its presence with offices across the United States, Europe, and Asia. As of early 2019, Janrain operates as a subsidiary of Akamai Technologies, further enhancing its capabilities in identity management.
Nexxo Financial
Series F in 2013
Nexxo Financial is a provider of a comprehensive range of everyday financial services designed to facilitate transactions for consumers and businesses. Its Everyday Financial Services Platform (EFS) allows businesses to offer integrated services such as check cashing, money transfers, bill payments, money orders, and pre-paid card servicing. Customers have the flexibility to access these services through various channels, including self-service kiosks, teller-assisted desktops, mobile applications, and web platforms. Additionally, Nexxo enables money transfers using debit cards, either over the phone or at designated locations, enhancing customer convenience and engagement. By leveraging technology to streamline access to financial products, Nexxo Financial aims to strengthen customer relationships and improve service delivery.
Sage Intacct
Venture Round in 2012
Sage Intacct, Inc. is a cloud accounting software company that specializes in delivering comprehensive financial management solutions for a variety of sectors including accounting, healthcare, hospitality, and nonprofits. Founded in 1999 and headquartered in San Jose, California, the company provides a robust suite of applications that encompass general ledger accounting, accounts payable, order management, cash management, financial reporting, and more. Sage Intacct also offers advanced functionalities such as project accounting, multi-entity consolidations, contract revenue management, and vendor payment services. The company focuses on customer success and innovation, serving clients from startups to public enterprises across North America. Sage Intacct is recognized for its exceptional customer satisfaction and has been appointed a preferred provider by the AICPA. With a commitment to cloud-based solutions, the company also offers extensive professional training and support services to enhance user experience.
Nuvaira
Series B in 2012
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.
ForSight VISION5
Venture Round in 2012
ForSight VISION5, founded in 2010 as part of ForSight Labs, specializes in developing innovative drug delivery technologies aimed at treating various eye conditions. The company focuses on creating non-invasive products designed to replace traditional eye drops, offering sustained therapy for significant eye diseases such as glaucoma, dry eye, and allergies. Currently, ForSight VISION5 is in its second Phase 2 clinical study for its lead product, the Helios insert, which represents a significant advancement in ocular treatment options.
Histogenics
Series C in 2012
Histogenics Corporation, founded in 2000 and headquartered in Waltham, Massachusetts, is a regenerative medicine company specializing in the development and commercialization of therapeutic medical products for musculoskeletal conditions. The company's innovative platform integrates cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to address cartilage damage and improve joint function. Its primary investigational product, NeoCart, is a tissue implant designed to treat cartilage injuries in the knee, aiming to regenerate healthy cartilage and enhance overall joint performance. In 2019, Histogenics was acquired by Ocugen, Inc., marking a significant transition in its corporate structure.
Zyga Technology
Series C in 2012
Zyga Technology, Inc. is a medical device company focused on developing and commercializing minimally invasive products for underserved conditions of the lumbar spine. The company offers the SImmetry Sacroiliac Joint Fusion System, which provides a surgical solution for sacroiliac joint fusion, addressing issues such as joint disruptions and degenerative sacroiliitis. Additionally, Zyga is working on the Glyder Facet Restoration System, an investigational device aimed at treating chronic facetogenic pain. Founded in 2008 and based in Minnetonka, Minnesota, Zyga Technology has assembled a skilled team with extensive experience in the spine industry. As of late 2017, Zyga operates as a subsidiary of RTI Surgical, Inc.
DFine
Venture Round in 2012
DFine Inc. is a medical device company based in San Jose, California, specializing in minimally invasive therapeutic devices for spinal pathologies, including metastatic spinal tumors and vertebral compression fractures. Founded in 2004, DFine develops advanced solutions such as the STAR tumor ablation system, which offers palliative treatment by ablating malignant lesions in the vertebral body. The company also provides vertebral augmentation systems designed for the percutaneous delivery of bone cement to treat pathological fractures, as well as vertebroplasty systems. In July 2016, DFine became a subsidiary of Merit Medical Systems, Inc., further enhancing its capacity to deliver innovative therapies for spine-related conditions.
Cayenne Medical
Venture Round in 2012
Cayenne Medical, Inc. is a medical device company specializing in soft tissue reconstruction solutions for the knee, shoulder, and extremities. Founded in 2005 and based in Scottsdale, Arizona, the company designs and markets a range of products aimed at improving surgical outcomes in sports medicine. Its offerings include the AperFix System, which facilitates anterior cruciate ligament (ACL) reconstruction using soft tissue grafts, as well as the AperFix II Cannulated Tibial Device and the AperFix Femoral Implant for anatomical soft tissue fixation. Cayenne Medical also provides the CrossFix II System for meniscal repair, the iFix for bone-tendon fixation, and the Cayenne Mirror Partial Knee System for early-stage knee arthritis treatment. In the shoulder category, the Quattro System addresses rotator cuff and labral repairs. Cayenne Medical operates as a subsidiary of Zimmer Biomet Holdings, enhancing its capacity to deliver innovative medical solutions.
BlueKai
Series D in 2012
BlueKai is a leading provider of enterprise data activation solutions designed to enhance intelligent marketing efforts. The company specializes in offering a comprehensive system that enables customers to manage and activate their first, second, and third-party data across various marketing channels and customer interactions. BlueKai's platform is notable for being the industry's first and most advanced Data Management Platform (DMP), as well as its highly connected Data Exchange. This end-to-end SaaS solution helps marketers and publishers maximize their cross-channel marketing efforts by leveraging data to achieve greater reach, scale, and efficiency. BlueKai collaborates with thousands of companies and is trusted by nearly half of the Fortune 30 brands to activate their data. The company has been recognized for its innovation, including being named to Forbes' "50 Most Promising US Companies" list in 2013.
Code42
Series A in 2012
Code42 specializes in data loss protection, visibility, and recovery solutions designed to safeguard critical information from various threats, including insider breaches. Its platform offers a secure cloud service that continuously and automatically collects data via a lightweight agent installed on devices, ensuring comprehensive protection for files on laptops and desktops. The company's solutions enable security, IT, and compliance professionals to quickly detect threats, meet regulatory requirements, and accelerate incident response without complex policy management or hindering user collaboration. By focusing on ease of use and effective data management, Code42 helps organizations maintain a secure environment while fostering a collaborative workplace culture.
Transcend Medical
Series B in 2012
Transcend Medical, Inc. is an ophthalmic device company dedicated to developing medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005 and based in Menlo Park, California, the company emerged from ForSight Labs and focuses on minimally invasive solutions to replace traditional invasive therapies. Its flagship product, the CyPass Micro-Stent, is designed to be inserted during routine cataract surgery to help reduce intraocular pressure. Transcend Medical also offers the Vold Gonio Lens for use in micro-invasive glaucoma surgery and provides clinical trial services. The CyPass Micro-Stent received CE mark approval in 2008 and has been evaluated in various clinical studies, including the COMPASS multi-center trial. The company operates as a subsidiary of Alcon Holdings, Inc.
DFine
Venture Round in 2011
DFine Inc. is a medical device company based in San Jose, California, specializing in minimally invasive therapeutic devices for spinal pathologies, including metastatic spinal tumors and vertebral compression fractures. Founded in 2004, DFine develops advanced solutions such as the STAR tumor ablation system, which offers palliative treatment by ablating malignant lesions in the vertebral body. The company also provides vertebral augmentation systems designed for the percutaneous delivery of bone cement to treat pathological fractures, as well as vertebroplasty systems. In July 2016, DFine became a subsidiary of Merit Medical Systems, Inc., further enhancing its capacity to deliver innovative therapies for spine-related conditions.
BlackDuck
Series E in 2011
Black Duck secures and manages open source software worldwide, eliminating open source security vulnerabilities and license compliance pain. With the rapid, widespread adoption of open-source software, Black Duck is a key component of Synopsys’ Software Integrity Platform, the most comprehensive solution for integrating security into the SDLC and software supply chain. Black Duck was established in 2002 and is based in Burlington, Massachusetts, United States.
RF Surgical Systems
Venture Round in 2011
RF Surgical Systems, Inc. specializes in detection technology aimed at preventing retained surgical sponges in hospitals and trauma centers across the United States. The company offers the RF Assure Detection System X, which is widely used in operating rooms, trauma, and labor and delivery suites, along with an array of handheld and motion-based scanning devices. Its products cater to various surgical applications, including procedures involving extremities, head, neck, spine, and other specialties. Founded in 2004 and headquartered in Carlsbad, California, RF Surgical Systems has established itself as a market leader in this field, with its technology employed in over 1,500 facilities nationwide. The company’s innovations are protected by U.S. patents, and it received regulatory clearance from the U.S. Food and Drug Administration in November 2006. As of August 2015, RF Surgical Systems operates as a subsidiary of Medtronic plc.
Entellus Medical
Series E in 2011
Entellus Medical, doing business as Stryker ENT, is a medical device company based in Plymouth, Minnesota, specializing in innovative solutions for ear, nose, and throat (ENT) treatments. Founded in 2006, Entellus develops and commercializes minimally invasive products aimed at addressing chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. Its product lineup includes the XprESS ENT dilation system, which offers versatility for sinus and eustachian tube procedures, and the FinESS Sinus Treatment, a direct and effective method for treating chronic rhinosinusitis that minimizes invasiveness and recovery time. The company also provides a range of surgical instruments, imaging solutions, and other tools that enhance patient care while reducing discomfort and the need for general anesthesia. By collaborating with researchers and clinicians, Entellus Medical works to meet the unmet needs of physicians and patients alike, thereby improving treatment outcomes in the ENT field.
Guardian Analytics
Series D in 2011
Guardian Analytics, Inc. is a provider of behavior-based fraud prevention solutions aimed at protecting financial institutions from online and mobile banking fraud. Established in 2005 and based in Mountain View, California, the company offers a range of services tailored for enterprise banks, community banks, and credit unions. These services include omni-channel fraud prevention, visual analytics, integrated risk databases, and cross-channel risk scoring. The platform utilizes behavioral analytics and machine learning to detect fraud in real-time across various payment methods, including online, mobile, ACH, and wire transfers. Additionally, Guardian Analytics provides a managed service called FraudDESK, which helps institutions mitigate fraud with minimal staffing impact. The company's solutions not only enhance fraud detection but also support anti-money laundering compliance, making them essential for over 400 financial institutions seeking to safeguard their operations and improve customer trust.
Transcend Medical
Series B in 2011
Transcend Medical, Inc. is an ophthalmic device company dedicated to developing medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005 and based in Menlo Park, California, the company emerged from ForSight Labs and focuses on minimally invasive solutions to replace traditional invasive therapies. Its flagship product, the CyPass Micro-Stent, is designed to be inserted during routine cataract surgery to help reduce intraocular pressure. Transcend Medical also offers the Vold Gonio Lens for use in micro-invasive glaucoma surgery and provides clinical trial services. The CyPass Micro-Stent received CE mark approval in 2008 and has been evaluated in various clinical studies, including the COMPASS multi-center trial. The company operates as a subsidiary of Alcon Holdings, Inc.
Sage Intacct
Venture Round in 2011
Sage Intacct, Inc. is a cloud accounting software company that specializes in delivering comprehensive financial management solutions for a variety of sectors including accounting, healthcare, hospitality, and nonprofits. Founded in 1999 and headquartered in San Jose, California, the company provides a robust suite of applications that encompass general ledger accounting, accounts payable, order management, cash management, financial reporting, and more. Sage Intacct also offers advanced functionalities such as project accounting, multi-entity consolidations, contract revenue management, and vendor payment services. The company focuses on customer success and innovation, serving clients from startups to public enterprises across North America. Sage Intacct is recognized for its exceptional customer satisfaction and has been appointed a preferred provider by the AICPA. With a commitment to cloud-based solutions, the company also offers extensive professional training and support services to enhance user experience.
8thBridge
Series B in 2011
8thBridge, headquartered in Minneapolis, Minnesota, is a Social Discovery platform that assists brands in enhancing product discovery and customer understanding. Founded in 2008, the company empowers brands to leverage social media for crowd-sourced content creation and deeper engagement with consumers. By focusing on the evolving dynamics between consumers and institutions, 8thBridge provides tools that enable retailers to gain valuable insights into customer behavior and preferences. The platform aims to convert social media interactions into measurable sales growth, addressing the challenges faced by marketing and e-commerce executives in monetizing their online presence. 8thBridge has collaborated with notable brands, including Ticketmaster and Delta Air Lines, and has been recognized as one of the top private companies in the world. It was acquired by Fluid, Inc. in April 2014 and is supported by investors such as Split Rock Partners and Trident Capital.
Sonoma Orthopedic Products
Series D in 2011
Sonoma Orthopedic Products is an orthopedic device company focused on designing, developing, and delivering proprietary orthopedic implants to address complex fractures. Utilizing the WaviBody technology platform, the company provides innovative surgical solutions that are minimally invasive, catering specifically to active patients. The firm specializes in fracture fixation devices that facilitate the repair of challenging bone geometries, enabling orthopedic surgeons to effectively restore function and return patients to their daily activities more rapidly. By prioritizing ease of use and efficacy in their products, Sonoma Orthopedic Products aims to enhance the recovery process for individuals with problematic fractures.
EBR Systems
Series D in 2011
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.
FamilyFinds
Series A in 2010
FamilyFinds is an online daily promotions site exclusively focused on services and experiences for families, allowing customers to save up to 90% on family-friendly activities, restaurants and services. Currently they offer exclusive deals in Los Angeles and Chicago, with support for more cities on the way. By offering daily deals from hidden gems to popular places, FamilyFinds allows consumers to discover new places to visit, ideas for local family adventures and other value-added content that takes them from deal to experience. Through its members-only daily email, the company shares deals on hand-picked local merchants and insider info on unique family experiences in specific, hyper local communities.
Nuvaira
Series A in 2010
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.
DFine
Venture Round in 2010
DFine Inc. is a medical device company based in San Jose, California, specializing in minimally invasive therapeutic devices for spinal pathologies, including metastatic spinal tumors and vertebral compression fractures. Founded in 2004, DFine develops advanced solutions such as the STAR tumor ablation system, which offers palliative treatment by ablating malignant lesions in the vertebral body. The company also provides vertebral augmentation systems designed for the percutaneous delivery of bone cement to treat pathological fractures, as well as vertebroplasty systems. In July 2016, DFine became a subsidiary of Merit Medical Systems, Inc., further enhancing its capacity to deliver innovative therapies for spine-related conditions.
8thBridge
Series A in 2010
8thBridge, headquartered in Minneapolis, Minnesota, is a Social Discovery platform that assists brands in enhancing product discovery and customer understanding. Founded in 2008, the company empowers brands to leverage social media for crowd-sourced content creation and deeper engagement with consumers. By focusing on the evolving dynamics between consumers and institutions, 8thBridge provides tools that enable retailers to gain valuable insights into customer behavior and preferences. The platform aims to convert social media interactions into measurable sales growth, addressing the challenges faced by marketing and e-commerce executives in monetizing their online presence. 8thBridge has collaborated with notable brands, including Ticketmaster and Delta Air Lines, and has been recognized as one of the top private companies in the world. It was acquired by Fluid, Inc. in April 2014 and is supported by investors such as Split Rock Partners and Trident Capital.
Twelve
Series A in 2010
Twelve manufactures medical devices. It was formerly known as Foundry Newco XII, Inc. The company was incorporated in 2009 and is based in Menlo Park, California.
Amcom Software
Private Equity Round in 2010
Amcom Software specializes in providing communication solutions tailored for organizations that require reliable and swift management of critical communications across various sectors, including healthcare, hospitality, government, corporate, and education. The company develops advanced software systems that enhance call center operations, emergency management, and messaging infrastructure. Its product offerings include PC-based attendant consoles, enterprise web communications, call center recording and quality management, and call accounting and reporting features. Amcom Software's solutions are designed to improve productivity and effectiveness in day-to-day and mission-critical communications, serving thousands of organizations that prioritize speed and accuracy in their communication processes.
EBR Systems
Venture Round in 2009
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.
Entellus Medical
Series D in 2009
Entellus Medical, doing business as Stryker ENT, is a medical device company based in Plymouth, Minnesota, specializing in innovative solutions for ear, nose, and throat (ENT) treatments. Founded in 2006, Entellus develops and commercializes minimally invasive products aimed at addressing chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. Its product lineup includes the XprESS ENT dilation system, which offers versatility for sinus and eustachian tube procedures, and the FinESS Sinus Treatment, a direct and effective method for treating chronic rhinosinusitis that minimizes invasiveness and recovery time. The company also provides a range of surgical instruments, imaging solutions, and other tools that enhance patient care while reducing discomfort and the need for general anesthesia. By collaborating with researchers and clinicians, Entellus Medical works to meet the unmet needs of physicians and patients alike, thereby improving treatment outcomes in the ENT field.
Caring.com
Series B in 2009
Caring.com, established in 2007, is a prominent online resource dedicated to assisting individuals who care for aging family members and loved ones. With a mission to alleviate the challenges faced by family caregivers, the platform provides essential information, support, and resources to help them make informed decisions while navigating their caregiving journeys. Catering to over 40 million caregivers in the United States, Caring.com offers a vast Senior Care Directory that includes nearly 55,000 consumer ratings and reviews, along with online support groups and a toll-free referral line for senior living options. The company's leadership team and staff possess extensive experience in health and family media, with many having personal caregiving experience. By delivering tailored guidance on senior living communities and home care agencies, Caring.com empowers caregivers to save time and money while reducing their stress.
eBureau
Series C in 2009
eBureau, LLC is a provider of big data and predictive analytic solutions tailored for both business-to-consumer and business-to-business sectors. Founded in 2004 and based in St. Cloud, Minnesota, the company offers a range of services designed to enhance decision-making throughout the customer lifecycle. These services include eScore for developing customized statistical scores, eVerify for verifying consumer identity, and eTarget for appending information to customer records. Additionally, eBureau provides eLink for account monitoring, eMonitor for visualizing transactional data, and eAuthenticate for knowledge-based authentication. The company's solutions are utilized in various industries, including higher education, insurance, financial services, automotive, telecom, utilities, and retail, focusing on marketing, fraud prevention, credit risk assessments, and collections. eBureau operates as a subsidiary of TransUnion, having rebranded from xTech LLC in 2007.
Xora
Venture Round in 2009
Xora is a global leader in mobile business applications. Our flagship solution is a suite of configurable cloud-based apps that help mobile businesses and their field employees work faster and smarter. Our apps turn any mobile device into powerful productivity and data collection tools. Our management application processes and reports data that can be used to make decisions that improve field operations. All of our solutions can be integrated with back-office systems and other applications to automate business processes and eliminate manual paperwork. More than 16,000 organizations rely on Xora every day to save money and grow their businesses. For more information, visit us at http://www.xora.com.
Nexis Vision
Series B in 2009
Nexis Vision develops ophthalmic solutions. The company is developing ocular surface technology for ophthalmic devices. The company was founded in 2007 and is based in Menlo Park, California. Nexis Vision, Inc. operates as a subsidiary of ForSight Labs, LLC.
Transcend Medical
Series B in 2009
Transcend Medical, Inc. is an ophthalmic device company dedicated to developing medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005 and based in Menlo Park, California, the company emerged from ForSight Labs and focuses on minimally invasive solutions to replace traditional invasive therapies. Its flagship product, the CyPass Micro-Stent, is designed to be inserted during routine cataract surgery to help reduce intraocular pressure. Transcend Medical also offers the Vold Gonio Lens for use in micro-invasive glaucoma surgery and provides clinical trial services. The CyPass Micro-Stent received CE mark approval in 2008 and has been evaluated in various clinical studies, including the COMPASS multi-center trial. The company operates as a subsidiary of Alcon Holdings, Inc.
Anulex Technologies
Series D in 2009
Anulex Technologies focus on developing proprietary medical technology to repair and seal the soft tissue of the spine (anulus) for patients undergoing a surgical procedure to remove a herniated disc (discectomy).
Atritech
Venture Round in 2009
Atritech is a Minneapolis-based private company founded in 2000, specializing in innovative medical technologies aimed at preventing strokes related to atrial fibrillation. The company's flagship product, the WATCHMAN Device, offers a minimally invasive solution for patients with non-valvular atrial fibrillation at risk of stroke by sealing off the left atrial appendage, thereby preventing blood clots from entering the bloodstream. The WATCHMAN Device was first implanted in Germany in 2002 and in the United States in 2003, and has since undergone extensive clinical trials to compare its efficacy against traditional long-term anticoagulation therapies. While the device is CE marked and available in several international markets, it is currently classified for investigational use only within the United States. Atritech's technology aims to enhance the quality of life for patients by providing a permanent alternative to anticoagulant medications.
Ardian
Series C in 2009
Ardian, established in 1996, is a France-based asset manager offering global investment management services. It primarily focuses on fund of funds (55.21%), followed by direct funds (19.79%), infrastructure (16.67%), and private debt (7.29%), with a minor allocation to real estate (1.04%). Ardian invests across various sectors, including food value chain, healthcare, technology, and industrials, with a presence in Europe and North America.
EBR Systems
Series C in 2008
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.
Entellus Medical
Series C in 2008
Entellus Medical, doing business as Stryker ENT, is a medical device company based in Plymouth, Minnesota, specializing in innovative solutions for ear, nose, and throat (ENT) treatments. Founded in 2006, Entellus develops and commercializes minimally invasive products aimed at addressing chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. Its product lineup includes the XprESS ENT dilation system, which offers versatility for sinus and eustachian tube procedures, and the FinESS Sinus Treatment, a direct and effective method for treating chronic rhinosinusitis that minimizes invasiveness and recovery time. The company also provides a range of surgical instruments, imaging solutions, and other tools that enhance patient care while reducing discomfort and the need for general anesthesia. By collaborating with researchers and clinicians, Entellus Medical works to meet the unmet needs of physicians and patients alike, thereby improving treatment outcomes in the ENT field.
Nexxo Financial
Series D in 2008
Nexxo Financial is a provider of a comprehensive range of everyday financial services designed to facilitate transactions for consumers and businesses. Its Everyday Financial Services Platform (EFS) allows businesses to offer integrated services such as check cashing, money transfers, bill payments, money orders, and pre-paid card servicing. Customers have the flexibility to access these services through various channels, including self-service kiosks, teller-assisted desktops, mobile applications, and web platforms. Additionally, Nexxo enables money transfers using debit cards, either over the phone or at designated locations, enhancing customer convenience and engagement. By leveraging technology to streamline access to financial products, Nexxo Financial aims to strengthen customer relationships and improve service delivery.
Miramar Labs
Series B in 2008
Miramar Labs is a company based in Sunnyvale, California, that specializes in developing medical devices for aesthetic purposes, particularly focusing on the treatment of primary axillary hyperhidrosis in adults. Founded in 2006, the company offers the miraDry System, which provides a non-invasive solution for excessive sweating and odor. This system employs microwave energy to selectively target and permanently eliminate sweat and odor glands in the underarm area. By addressing these concerns, Miramar Labs aims to enhance the confidence and quality of life for individuals suffering from this condition. However, the miraDry System is not designed to treat hyperhidrosis in other areas of the body, such as the hands and feet.
Cayenne Medical
Series C in 2008
Cayenne Medical, Inc. is a medical device company specializing in soft tissue reconstruction solutions for the knee, shoulder, and extremities. Founded in 2005 and based in Scottsdale, Arizona, the company designs and markets a range of products aimed at improving surgical outcomes in sports medicine. Its offerings include the AperFix System, which facilitates anterior cruciate ligament (ACL) reconstruction using soft tissue grafts, as well as the AperFix II Cannulated Tibial Device and the AperFix Femoral Implant for anatomical soft tissue fixation. Cayenne Medical also provides the CrossFix II System for meniscal repair, the iFix for bone-tendon fixation, and the Cayenne Mirror Partial Knee System for early-stage knee arthritis treatment. In the shoulder category, the Quattro System addresses rotator cuff and labral repairs. Cayenne Medical operates as a subsidiary of Zimmer Biomet Holdings, enhancing its capacity to deliver innovative medical solutions.
Nexis Vision
Series A in 2008
Nexis Vision develops ophthalmic solutions. The company is developing ocular surface technology for ophthalmic devices. The company was founded in 2007 and is based in Menlo Park, California. Nexis Vision, Inc. operates as a subsidiary of ForSight Labs, LLC.
Kspine
Series A in 2008
Kspine was developing implantable medical devices for the treatment of spine disorders.
Calabrio
Series B in 2007
Calabrio, Inc. is a customer experience intelligence company that specializes in developing workforce optimization software solutions for call centers. Founded in 2007 and headquartered in Minneapolis, Minnesota, Calabrio offers the Calabrio ONE software suite, which integrates various modules for call recording, quality management, workforce management, analytics, and reporting. This suite is designed to enhance agent engagement and optimize performance, catering to the evolving demands of contact centers. The company serves a diverse range of industries, including healthcare, telecommunications, retail, and finance, providing services such as project management, implementation, training, and technical support. With over 4,000 clients globally, Calabrio's web-based architecture positions contact centers as key drivers of customer insight, facilitating strategic business growth through enhanced customer interactions. The company also has additional locations in Vancouver, London, Singapore, and Stockholm, and is recognized for its innovative contributions in the workforce optimization sector.
Evalve
Series D in 2007
Evalve, Inc. engages in the design, development, manufacture, and marketing of devices that enable the repair of cardiac valves. It provides a non-surgical mitral valve repair system consisting of a steerable guide catheter, a clip delivery system, and an implant device that is used by interventional cardiologists to reduce mitral regurgitation. The company was incorporated in 1999 and is based in Menlo Park, California.
Atritech
Series D in 2007
Atritech is a Minneapolis-based private company founded in 2000, specializing in innovative medical technologies aimed at preventing strokes related to atrial fibrillation. The company's flagship product, the WATCHMAN Device, offers a minimally invasive solution for patients with non-valvular atrial fibrillation at risk of stroke by sealing off the left atrial appendage, thereby preventing blood clots from entering the bloodstream. The WATCHMAN Device was first implanted in Germany in 2002 and in the United States in 2003, and has since undergone extensive clinical trials to compare its efficacy against traditional long-term anticoagulation therapies. While the device is CE marked and available in several international markets, it is currently classified for investigational use only within the United States. Atritech's technology aims to enhance the quality of life for patients by providing a permanent alternative to anticoagulant medications.
Caring.com
Series A in 2007
Caring.com, established in 2007, is a prominent online resource dedicated to assisting individuals who care for aging family members and loved ones. With a mission to alleviate the challenges faced by family caregivers, the platform provides essential information, support, and resources to help them make informed decisions while navigating their caregiving journeys. Catering to over 40 million caregivers in the United States, Caring.com offers a vast Senior Care Directory that includes nearly 55,000 consumer ratings and reviews, along with online support groups and a toll-free referral line for senior living options. The company's leadership team and staff possess extensive experience in health and family media, with many having personal caregiving experience. By delivering tailored guidance on senior living communities and home care agencies, Caring.com empowers caregivers to save time and money while reducing their stress.
Mirabilis Medical
Series A in 2007
Mirabilis Medical, Inc. is a medical device company based in Bothell, Washington, that specializes in the development and manufacture of ultrasound devices aimed at the non-invasive treatment of uterine fibroids, a common condition affecting women. Established in 2004, the company provides innovative solutions for gynecologists, utilizing high-resolution ultrasound imaging to accurately locate and treat fibroid tissue deep within the body without the need for incisions or punctures. This proprietary technology allows for effective ablation of pathological tissue while minimizing damage to surrounding areas, positioning Mirabilis Medical as a key player in the field of gynecological treatments.
Compete
Series C in 2007
Compete, Inc. specializes in digital intelligence services aimed at enhancing marketing strategies for brands by analyzing consumer online behavior. The company provides valuable insights into consumer behavior, enabling businesses to research competitors, benchmark performance, and identify effective keywords and referral sources. Compete offers tools to track online market shares among competitors and product categories, analyze traffic sources, and improve website engagement and conversion metrics. Additionally, it helps identify cross-selling and up-selling opportunities, measure referral partnerships, and reduce customer care costs, all while fostering customer loyalty through actionable intelligence. The company also focuses on mobile behavioral intelligence to understand the impact of mobile devices on consumer shopping experiences, further enriching its data-driven insights for brands.
eBureau
Series B in 2007
eBureau, LLC is a provider of big data and predictive analytic solutions tailored for both business-to-consumer and business-to-business sectors. Founded in 2004 and based in St. Cloud, Minnesota, the company offers a range of services designed to enhance decision-making throughout the customer lifecycle. These services include eScore for developing customized statistical scores, eVerify for verifying consumer identity, and eTarget for appending information to customer records. Additionally, eBureau provides eLink for account monitoring, eMonitor for visualizing transactional data, and eAuthenticate for knowledge-based authentication. The company's solutions are utilized in various industries, including higher education, insurance, financial services, automotive, telecom, utilities, and retail, focusing on marketing, fraud prevention, credit risk assessments, and collections. eBureau operates as a subsidiary of TransUnion, having rebranded from xTech LLC in 2007.
CareParent
Series A in 2007
CareParent Inc. provides online services which include elder care information and resources. The company is based in Palo Alto, California.
Entellus Medical
Series B in 2007
Entellus Medical, doing business as Stryker ENT, is a medical device company based in Plymouth, Minnesota, specializing in innovative solutions for ear, nose, and throat (ENT) treatments. Founded in 2006, Entellus develops and commercializes minimally invasive products aimed at addressing chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. Its product lineup includes the XprESS ENT dilation system, which offers versatility for sinus and eustachian tube procedures, and the FinESS Sinus Treatment, a direct and effective method for treating chronic rhinosinusitis that minimizes invasiveness and recovery time. The company also provides a range of surgical instruments, imaging solutions, and other tools that enhance patient care while reducing discomfort and the need for general anesthesia. By collaborating with researchers and clinicians, Entellus Medical works to meet the unmet needs of physicians and patients alike, thereby improving treatment outcomes in the ENT field.
ForSight Labs
Series A in 2007
ForSight Labs is dedicated to developing innovative ophthalmic technologies aimed at enhancing the sight and quality of life for visually impaired patients. The organization collaborates with entrepreneurs, investors, and clinicians to drive advancements in eye care through the creation and commercialization of high-impact solutions. With millions of individuals in the U.S. suffering from vision impairment and the associated economic burden exceeding $50 billion annually, ForSight Labs addresses a significant public health challenge. Their focus includes developing treatments for conditions such as glaucoma, which can lead to irreversible blindness in adults. By fostering a creative and cooperative environment, ForSight Labs strives to deliver effective solutions to the ophthalmic community and the patients it serves.
Gearworks
Venture Round in 2007
Gearworks specializes in location-based mobile business applications, partnering with wireless carriers to help customers effectively manage their mobile resources. The company offers a range of products under the etrace, Field Force Manager, appmosphere, and OnCare brands, providing carrier-class mobile management software solutions. In addition to software, Gearworks delivers phone programming, provisioning, training, customization, and integration services. Its customer base includes small to medium-sized businesses and enterprises across various industries, such as construction, healthcare, field service, home and store delivery, utilities, and government services.
Cayenne Medical
Series B in 2007
Cayenne Medical, Inc. is a medical device company specializing in soft tissue reconstruction solutions for the knee, shoulder, and extremities. Founded in 2005 and based in Scottsdale, Arizona, the company designs and markets a range of products aimed at improving surgical outcomes in sports medicine. Its offerings include the AperFix System, which facilitates anterior cruciate ligament (ACL) reconstruction using soft tissue grafts, as well as the AperFix II Cannulated Tibial Device and the AperFix Femoral Implant for anatomical soft tissue fixation. Cayenne Medical also provides the CrossFix II System for meniscal repair, the iFix for bone-tendon fixation, and the Cayenne Mirror Partial Knee System for early-stage knee arthritis treatment. In the shoulder category, the Quattro System addresses rotator cuff and labral repairs. Cayenne Medical operates as a subsidiary of Zimmer Biomet Holdings, enhancing its capacity to deliver innovative medical solutions.
Transcend Medical
Series A in 2006
Transcend Medical, Inc. is an ophthalmic device company dedicated to developing medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005 and based in Menlo Park, California, the company emerged from ForSight Labs and focuses on minimally invasive solutions to replace traditional invasive therapies. Its flagship product, the CyPass Micro-Stent, is designed to be inserted during routine cataract surgery to help reduce intraocular pressure. Transcend Medical also offers the Vold Gonio Lens for use in micro-invasive glaucoma surgery and provides clinical trial services. The CyPass Micro-Stent received CE mark approval in 2008 and has been evaluated in various clinical studies, including the COMPASS multi-center trial. The company operates as a subsidiary of Alcon Holdings, Inc.
MyNewPlace
Series B in 2006
MyNewPlace is a prominent apartment listing website in the United States, facilitating connections between landlords and potential tenants. The platform offers a comprehensive search feature for apartments and homes for rent, along with valuable city information and demographic data. Users can access property details, including photos and videos, as well as integrated mapping to enhance their search experience. MyNewPlace is recognized for its user-friendly design and was a pioneer in incorporating social networking features into the rental process. The company also provides resources such as rental living tips through its blog, LocalTalk. Founded in San Francisco's SoMa neighborhood, MyNewPlace is owned by RealPage, headquartered in Carrollton, Texas. In 2009, the company expanded its offerings with a mobile app that includes GPS-based apartment searches and note-taking capabilities for listings.
Anulex Technologies
Series C in 2006
Anulex Technologies focus on developing proprietary medical technology to repair and seal the soft tissue of the spine (anulus) for patients undergoing a surgical procedure to remove a herniated disc (discectomy).
Entellus Medical
Series A in 2006
Entellus Medical, doing business as Stryker ENT, is a medical device company based in Plymouth, Minnesota, specializing in innovative solutions for ear, nose, and throat (ENT) treatments. Founded in 2006, Entellus develops and commercializes minimally invasive products aimed at addressing chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. Its product lineup includes the XprESS ENT dilation system, which offers versatility for sinus and eustachian tube procedures, and the FinESS Sinus Treatment, a direct and effective method for treating chronic rhinosinusitis that minimizes invasiveness and recovery time. The company also provides a range of surgical instruments, imaging solutions, and other tools that enhance patient care while reducing discomfort and the need for general anesthesia. By collaborating with researchers and clinicians, Entellus Medical works to meet the unmet needs of physicians and patients alike, thereby improving treatment outcomes in the ENT field.
Atritech
Series C in 2006
Atritech is a Minneapolis-based private company founded in 2000, specializing in innovative medical technologies aimed at preventing strokes related to atrial fibrillation. The company's flagship product, the WATCHMAN Device, offers a minimally invasive solution for patients with non-valvular atrial fibrillation at risk of stroke by sealing off the left atrial appendage, thereby preventing blood clots from entering the bloodstream. The WATCHMAN Device was first implanted in Germany in 2002 and in the United States in 2003, and has since undergone extensive clinical trials to compare its efficacy against traditional long-term anticoagulation therapies. While the device is CE marked and available in several international markets, it is currently classified for investigational use only within the United States. Atritech's technology aims to enhance the quality of life for patients by providing a permanent alternative to anticoagulant medications.
eBureau
Series A in 2006
eBureau, LLC is a provider of big data and predictive analytic solutions tailored for both business-to-consumer and business-to-business sectors. Founded in 2004 and based in St. Cloud, Minnesota, the company offers a range of services designed to enhance decision-making throughout the customer lifecycle. These services include eScore for developing customized statistical scores, eVerify for verifying consumer identity, and eTarget for appending information to customer records. Additionally, eBureau provides eLink for account monitoring, eMonitor for visualizing transactional data, and eAuthenticate for knowledge-based authentication. The company's solutions are utilized in various industries, including higher education, insurance, financial services, automotive, telecom, utilities, and retail, focusing on marketing, fraud prevention, credit risk assessments, and collections. eBureau operates as a subsidiary of TransUnion, having rebranded from xTech LLC in 2007.
ForSight Labs
Venture Round in 2006
ForSight Labs is dedicated to developing innovative ophthalmic technologies aimed at enhancing the sight and quality of life for visually impaired patients. The organization collaborates with entrepreneurs, investors, and clinicians to drive advancements in eye care through the creation and commercialization of high-impact solutions. With millions of individuals in the U.S. suffering from vision impairment and the associated economic burden exceeding $50 billion annually, ForSight Labs addresses a significant public health challenge. Their focus includes developing treatments for conditions such as glaucoma, which can lead to irreversible blindness in adults. By fostering a creative and cooperative environment, ForSight Labs strives to deliver effective solutions to the ophthalmic community and the patients it serves.
BigFix
Series E in 2005
BigFix, Inc. offers an IT security and operations platform designed for real-time visibility and control of distributed computing environments, including desktops, mobile devices, and servers. The BigFix Platform enables effective management of IT infrastructures by providing tools for endpoint security, policy enforcement, and automated operations tasks. Key features include asset discovery, patch management, remote control, and software distribution services. Additionally, BigFix provides custom management content through its Policy Content Modules and offers various support and professional services. Established in 1997 and based in Emeryville, California, the company serves a diverse client base, including businesses, government agencies, and public sector institutions.
EBR Systems
Series B in 2005
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.